Skip to content
PubMed This is a summary of 7 peer-reviewed journal articles Updated

How the Condition Changes Over Time

At a Glance

Nakajo-Nishimura syndrome often begins in early childhood with recurring fevers and skin changes, then may lead to loss of body fat and muscle, stiff joints, and effects on internal organs. Symptoms vary, so regular specialist monitoring helps distinguish active inflammation from lasting changes.

Nakajo-Nishimura Syndrome (NNS) is a progressive condition, meaning that symptoms often change and evolve as a person grows. While every person’s experience is unique, researchers have identified a “classic” progression that usually begins with skin rashes and fevers before moving toward changes in body shape and joint mobility [1][2].

It is important to distinguish between symptoms of active inflammation (which fluctuate and may respond to medication) and established changes (which are often permanent) [1].

The First Signs: Rashes and Fevers

For most people, the earliest signs of NNS involve the skin and the body’s internal thermostat. These symptoms often appear in infancy or early childhood and may include:

  • Periodic Fevers: These are fevers that come and go at somewhat regular intervals [2]. In some cases, cold weather seems to trigger or worsen these fever episodes [3].
  • Pernio-like Lesions: You may notice red or purplish patches on the nose, cheeks, hands, and feet [4]. These often look like chilblains (painful inflammation of small blood vessels in response to cold) [2].
  • Panniculitic Nodules: These are tender, red bumps that usually form under the skin [2]. They are caused by panniculitis, which is inflammation of the fat layer just beneath the skin’s surface [5].

Changes in Appearance: Lipomuscular Atrophy

As the condition progresses, a hallmark of NNS is the loss of both body fat and muscle, a process called lipomuscular atrophy [4]. This typically follows a specific pattern:

  • Upper Body Focus: The loss of fat and muscle is usually most noticeable in the face, neck, and upper trunk [2]. A person may develop a very thin appearance in these areas while the lower body remains less affected [2].
  • Muscle Weakness: Along with the loss of fat, the muscles themselves can be affected [1]. This weakness can be due to active muscle inflammation (myositis), but it can also reflect established atrophy, joint stiffness, or deconditioning [1].
  • Cellular Stress: This loss happens because the defective proteasome function causes cellular stress and chronic inflammatory signaling that impacts the fat and muscle tissue [6][7].

Hand and Joint Changes

The inflammation in NNS also affects the small joints and the shape of the fingers and toes.

  • Clubbed Fingers: Many people develop fingers and toes that appear unusually long and have widened, rounded tips, known as clubbing [4].
  • Joint Contractures: Over time, chronic inflammation and muscle loss can lead to joint contractures, where the joints become stiff and fixed in a bent position [4]. This most commonly affects the fingers, making it hard to fully straighten the hand [2].
  • Acrocyanosis: The fingers and toes may also appear blue or cold, especially in lower temperatures, due to changes in blood flow [3].

Systemic (Body-Wide) Involvement

Because NNS is a systemic inflammatory disease, it can affect internal organs and the brain in ways that aren’t visible from the outside.

  • Organ Enlargement: Some individuals may develop an enlarged liver (hepatomegaly) or spleen (splenomegaly) as the immune system remains in a state of high alert [4][2].
  • Basal Ganglia Calcification: In some cases, imaging ordered for specific neurologic findings may show small calcium deposits in the basal ganglia, a part of the brain that helps control movement [2][4].
  • Amyloidosis Risk: In rare instances of long-term, uncontrolled inflammation, a protein called amyloid can build up in the organs, particularly the kidneys. This is known as AA amyloidosis and requires close medical monitoring [3].

The severity of these symptoms can vary widely. Some people may have very mild skin signs for years, while others may experience more rapid progression of muscle weakness and fat loss [1][3]. Consistent monitoring by a team of specialists is the best way to track these changes and adjust treatments as needed.

Common questions in this guide

At what age do Nakajo-Nishimura syndrome symptoms usually begin?
The earliest signs often appear in infancy or early childhood. Recurring fevers and skin changes, such as red or purple cold-sensitive patches or tender bumps under the skin, are common early features.
How can NNS change a person’s appearance as it progresses?
Some people gradually lose both fat and muscle, especially in the face, neck, and upper trunk; this is called lipomuscular atrophy. The lower body may be less affected, and the visible changes may become established over time.
Why might someone with NNS have weak or stiff muscles?
Weakness can result from active muscle inflammation, established loss of muscle tissue, joint stiffness, or reduced conditioning. A specialist team can assess the pattern over time to help determine which factors are contributing.
What hand and foot changes can occur with Nakajo-Nishimura syndrome?
The fingers and toes may become unusually long with widened, rounded tips, a change called clubbing. Joint contractures can make the fingers stiff and partly bent, and cold temperatures may cause the digits to feel cold or look blue.
Which internal complications should families watch for in NNS?
Some people develop an enlarged liver or spleen, and brain imaging may show calcium deposits in a movement-control area called the basal ganglia. Rarely, long-term uncontrolled inflammation can cause AA amyloidosis, in which a protein builds up in organs, especially the kidneys.
Can cold weather make Nakajo-Nishimura syndrome symptoms worse?
Cold weather may trigger or worsen fever episodes and may make chilblain-like skin lesions, coldness, or blue coloring of the fingers and toes more noticeable. Recording when these changes occur can give the clinical team useful information.
How can physical or occupational therapy help someone with NNS?
Physical and occupational therapy may help manage stiffness and support movement and daily tasks, but routines should be individualized. The care team can recommend activities that fit the person’s current inflammation, joint mobility, and muscle strength.

Get notified when new evidence is published on Nakajo-Nishimura syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (7)
  1. 1

    Myositis with sarcoplasmic inclusions in Nakajo-Nishimura syndrome: a genetic inflammatory myopathy.

    Ayaki T, Murata K, Kanazawa N, et al.

    Neuropathology and applied neurobiology 2020; (46(6)):579-587 doi:10.1111/nan.12614.

    PMID: 32144790
  2. 2

    Nakajo-Nishimura syndrome and related proteasome-associated autoinflammatory syndromes.

    Ohmura K

    Journal of inflammation research 2019; (12()):259-265 doi:10.2147/JIR.S194098.

    PMID: 31576159
  3. 3

    Nakajo-Nishimura Syndrome: The First African Case.

    Ghodbane NE, Mecibah A, Merzougui Z, et al.

    Mediterranean journal of rheumatology 2023; (34(2)):262-265 doi:10.31138/mjr.34.2.262.

    PMID: 37654638
  4. 4

    A Chinese case of Nakajo-Nishimura syndrome with novel compound heterozygous mutations of the PSMB8 gene.

    Jia T, Zheng Y, Feng C, et al.

    BMC medical genetics 2020; (21(1)):126 doi:10.1186/s12881-020-01060-8.

    PMID: 32513120
  5. 5

    Panniculitis: A Cardinal Sign of Autoinflammation.

    Borges T, Silva S

    Current rheumatology reviews 2024; (20(4)):350-360 doi:10.2174/0115733971254702231020060633.

    PMID: 37921131
  6. 6

    Pluripotent Stem Cell Model of Nakajo-Nishimura Syndrome Untangles Proinflammatory Pathways Mediated by Oxidative Stress.

    Honda-Ozaki F, Terashima M, Niwa A, et al.

    Stem cell reports 2018; (10(6)):1835-1850 doi:10.1016/j.stemcr.2018.04.004.

    PMID: 29731430
  7. 7

    Induced pluripotent stem cells representing Nakajo-Nishimura syndrome.

    Kanazawa N, Honda-Ozaki F, Saito MK

    Inflammation and regeneration 2019; (39()):11 doi:10.1186/s41232-019-0099-8.

    PMID: 31143302

This page describes possible changes in Nakajo-Nishimura syndrome for informational purposes only and does not constitute medical advice. Your specialist team should interpret symptoms and recommend monitoring for you or your child.